Doug Schenkel
Stock Analyst at Wolfe Research
(2.92)
# 1,472
Out of 5,130 analysts
70
Total ratings
55.77%
Success rate
34.21%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Upgrades: Outperform | $60 | $54.46 | +10.17% | 3 | Dec 10, 2025 | |
| WAT Waters | Upgrades: Outperform | $480 | $396.75 | +20.98% | 2 | Dec 10, 2025 | |
| GH Guardant Health | Upgrades: Outperform | $75 | $110.17 | -31.92% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $28.51 | +12.24% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $66.27 | -9.46% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $74.87 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $35.32 | +69.88% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $21.06 | +32.95% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $275.52 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $166.82 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $3.93 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $285 | $238.37 | +19.56% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $148.52 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $49 | $48.29 | +1.57% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $20.46 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $141.07 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $102.11 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $618.86 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.58 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $104.43 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.94 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $12.41 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $234.31 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.29 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.34 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.69 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.40 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.95 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $23.30 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $1.64 | +997.56% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $21.70 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $289.04 | -68.86% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $8.06 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $192.67 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $67.40 | -76.26% | 2 | Sep 28, 2017 |
Bruker
Dec 10, 2025
Upgrades: Outperform
Price Target: $60
Current: $54.46
Upside: +10.17%
Waters
Dec 10, 2025
Upgrades: Outperform
Price Target: $480
Current: $396.75
Upside: +20.98%
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $110.17
Upside: -31.92%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $28.51
Upside: +12.24%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $66.27
Upside: -9.46%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $74.87
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $35.32
Upside: +69.88%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $21.06
Upside: +32.95%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $275.52
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $166.82
Upside: -
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.93
Upside: -
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $238.37
Upside: +19.56%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $148.52
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $49
Current: $48.29
Upside: +1.57%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $20.46
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $141.07
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $102.11
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $618.86
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $6.58
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $104.43
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.94
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $12.41
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $234.31
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.29
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $3.34
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.69
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.40
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.95
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $23.30
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $1.64
Upside: +997.56%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $21.70
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $289.04
Upside: -68.86%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $8.06
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $192.67
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $67.40
Upside: -76.26%